Lupin receives FDA approval for potassium chloride extended-release capsules
It is indicated for the treatment of patients with hypokalemia, with or without metabolic alkalosis, in digitalis intoxications…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cystic fibrosis therapies will push Vertex ahead of GSK in respiratory market by 2022: GBI Research
The respiratory market is expected to rise considerably from $28.1 billion in 2015 to $46.6 billion by 2022, at a CAGR of 7.5 per…
Strides Shasun’s Q1 FY17 pharma revenues grow 43 per cent YoY
To carve out API commodity division as increasing compliance costs cut margins
Lupin, Sun Pharma, Cipla and DRL top India’s Most Reputed Pharmaceutical Brands list
The study evaluates the brand reputation by analysing media perception and consumer perceptions
Aurobindo Pharma forms JV with Tergene Biotech to develop PCV
To set up a vaccine manufacturing facility as it plans to launch its vaccine products commercially in 2018
PharmaLytica 2016 concludes successfully in Mumbai
It brought the pharma fraternity under one roof to witness the latest industry trends, innovations and conduct business with…
Waters recognises Dr Sunghwan Kim of Kyungpook National University
Dr Kim is an expert on developing and applying analytical techniques for assessing the impact of Polynuclear Aromatic Hydrocarbons…
Veeva opens office in Mumbai to expand presence in APAC
The team in Mumbai will serve the needs for cloud and mobility solutions among life sciences customers throughout India,…
Piramal Enterprises signs agreement to acquire Ash Stevens, US CDMO for HPAPIs
The facility has approvals from US, EU, Australia, Japan, Korea, Mexico regulatory agencies
IPM clocks Rs 9125 crores in July 2016
The Odisha market grew the highest at 17.9 per cent followed by Bihar and South Maharashtra